United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2334,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "28b4fd32-4bf1-44a2-83b0-a82e6f301179",
"title": "Pfizer's (PFE) Braftovi Combo Boosts Survival in Cancer Trial",
"description": "Pfizer's late-stage trial shows significant advancements in Braftovi therapy for specific colorectal cancer. Analysts provide a cautiously optimistic pr",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer's late-stage trial shows significant advancements in Braftovi therapy for specific colorectal cancer.\n\nAnalysts provide a cautiously optimistic price for...",
"url": "https://www.gurufocus.com/news/2898786/pfizers-pfe-braftovi-combo-boosts-survival-in-cancer-trial",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-05-30T15:55:57.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 31.668076,
"sentiment_score": 0.238067,
"highlights": [
{
"highlight": "Analysts provide a cautiously optimistic[+238 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) has r[+137 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nAccording[+289 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into the estimates, yo[+240 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Moreover, GuruFocus estimates project th[+171 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights, please refer[+56 characters]",
"sentiment": 0.3804,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 31.668076,
"sentiment_score": 0.238067,
"highlights": [
{
"highlight": "Analysts provide a cautiously optimistic[+238 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) has r[+137 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nAccording[+289 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into the estimates, yo[+240 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Moreover, GuruFocus estimates project th[+171 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights, please refer[+56 characters]",
"sentiment": 0.3804,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "d6452259-8837-48fe-820e-a7809705252b",
"title": "Pfizer Inc (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"description": "Summary Pfizer Inc (PFE) has announced significant findings from the Phase 3 BREAKWATER trial, which evaluated the efficacy of BRAFTOVI® (encorafenib) in combi",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Summary\n\nPfizer Inc (PFE, Financial) has announced significant findings from the Phase 3 BREAKWATER trial, which evaluated the efficacy of BRAFTOVI® (encorafen...",
"url": "https://www.gurufocus.com/news/2898531/pfizer-inc-pfe-announces-promising-results-from-breakwater-trial-for-metastatic-colorectal-cancer-pfe-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T14:02:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.753826,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 58.753838,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.752995,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 58.75512,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 58.75499,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.75499,
"sentiment_score": -0.336967,
"highlights": [
{
"highlight": "Summary\n\n<em>Pfizer</em> <em>Inc</em> (P[+272 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+272 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) Announces Promising Results from BREAKWATER Trial for Metastatic Colorectal Cancer | PFE stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "5b5fe96f-408a-4305-80de-2e96871ae453",
"title": "Pfizer (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"description": "Pfizer (PFE) has disclosed encouraging outcomes from its Phase 3 BREAKWATER study, showcasing significant survival benefits of BRAFTOVI when combined with cetux",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer (PFE, Financial) has disclosed encouraging outcomes from its Phase 3 BREAKWATER study, showcasing significant survival benefits of BRAFTOVI when combined...",
"url": "https://www.gurufocus.com/news/2898383/pfizer-pfe-reveals-promising-results-from-phase-3-colorectal-cancer-trial-pfe-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-05-30T13:46:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE.DE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.22515,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.224297,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 42.224304,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.223816,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 42.22512,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 42.22503,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.22503,
"sentiment_score": 0.335989,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has dis[+242 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+265 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is ex[+220 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) is le[+135 characters]",
"sentiment": -0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Reveals Promising Results from Phase 3 Colorectal Cancer Trial | PFE Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "0aec3ea3-224b-4deb-822a-7f36fa517e20",
"title": "Merck (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"description": "Merck (MRK), also known as MSD outside of the U.S. and Canada, has shared new findings from the dose confirmation phase of its Phase 2/3 waveLINE-003 study. Thi",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRK",
"snippet": "Merck (MRK, Financial), also known as MSD outside of the U.S. and Canada, has shared new findings from the dose confirmation phase of its Phase 2/3 waveLINE-003...",
"url": "https://www.gurufocus.com/news/2898349/merck-mrk-reports-promising-phase-23-trial-results-for-cancer-therapy-mrk-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008C5.png?20",
"language": "en",
"published_at": "2025-05-30T13:30:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "6MK.DE",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.6661,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRK.PA",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.66568,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.665375,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRK.MX",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.663372,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRKD.BA",
"name": "MERCK & CO INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 51.661713,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRK.SN",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.661232,
"sentiment_score": 0.080417,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), also kn[+136 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Merck</em> (MRK) Reports Promising Phase 2/3 Trial Results for Cancer Therapy | MRK Stock News",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "734fdde7-c1a2-46e9-b3fc-56ee4447a33e",
"title": "Pfizer's BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer | PFE Stock News",
"description": "Pfizer's BRAFTOVI® combination regimen reduces the risk of death by 51% for patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC). The Ph",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer's BRAFTOVI® combination regimen reduces the risk of death by 51% for patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC).\n\nThe Phase 3 B...",
"url": "https://www.gurufocus.com/news/2898324/pfizers-braftovi-combination-regimen-cuts-the-risk-of-death-in-half-for-patients-with-braf-v600emutant-metastatic-colorectal-cancer-pfe-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-05-30T13:17:38.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.627789,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 21.627789,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 21.627716,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 21.627722,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.627722,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.DE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.626026,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.625809,
"sentiment_score": 0.16975,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+280 characters]",
"sentiment": -0.1372,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> is currently in discussi[+89 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "57813928-2670-48b1-948f-3da1ca204831",
"title": "Summit Therapeutics (SMMT) Advances Lung Cancer Drug with Positive Trial Results",
"description": "Summit Therapeutics' lead treatment, ivonescimab, achieves a major milestone in a Phase 3 lung cancer trial. Analysts project a significant potential up",
"keywords": "GuruFocus, Article, News, GuruFocus News, SMMT",
"snippet": "Summit Therapeutics' lead treatment, ivonescimab, achieves a major milestone in a Phase 3 lung cancer trial.\n\nAnalysts project a significant potential upside fo...",
"url": "https://www.gurufocus.com/news/2898193/summit-therapeutics-smmt-advances-lung-cancer-drug-with-positive-trial-results",
"image_url": "https://static.gurufocus.com/logos/0C00000MNE.png?20",
"language": "en",
"published_at": "2025-05-30T12:56:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMMT",
"name": "Summit Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 70.918686,
"sentiment_score": -0.11348,
"highlights": [
{
"highlight": "<em>Summit</em> <em>Therapeutics</em>' l[+288 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Summit</em> <em>Therapeutics</em> (S[+209 characters]",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nTurning t[+314 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "For investors seeking more detailed fore[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Summit</em> <em>Therapeutics</em> (SMMT) Advances Lung Cancer Drug with Positive Trial Results",
"sentiment": -0.2023,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "d7f28c49-60ea-4f72-89f9-6b0d28cacb2b",
"title": "Strathcona (STHRF) Makes C$5.9B Bid for MEG Energy",
"description": "Strathcona Resources proposes to acquire MEG Energy in a C$5.9 billion deal. The offer consists of both cash and stock, providing a premium to MEG's rec",
"keywords": "GuruFocus, Article, News, GuruFocus News, STHRF",
"snippet": "Strathcona Resources proposes to acquire MEG Energy in a C$5.9 billion deal.\n\nThe offer consists of both cash and stock, providing a premium to MEG's recent sha...",
"url": "https://www.gurufocus.com/news/2898784/strathcona-sthrf-makes-c59b-bid-for-meg-energy",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T15:55:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MEGEF",
"name": "MEG Energy Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 73.70972,
"sentiment_score": 0.406367,
"highlights": [
{
"highlight": "Strathcona Resources proposes to acquire[+214 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Strathcona Resources' Bold Acquisition M[+323 characters]",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "Strathcona (STHRF) Makes C$5.9B Bid for <em>MEG</em> <em>Energy</em>",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "6261ac90-a0dc-4027-a5ee-fad4848a7c06",
"title": "SHARC Energy Announces Q1 2025 Financial Results",
"description": "VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) ( INTWF) (\"SHARC Energy\" or the ”Comp",
"keywords": "GuruFocus, Article, News, Marketwired, INTWF",
"snippet": "VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) ( INTWF) (\"SHARC Energy\" or the “Compan...",
"url": "https://www.gurufocus.com/news/2898214/sharc-energy-announces-q1-2025-financial-results",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T13:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "INTWF",
"name": "Sharc International Systems Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 50.232864,
"sentiment_score": 0.568567,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia, May 30, 202[+356 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "About SHARC Energy\n\n<em>SHARC</em> <em>I[+139 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "SHARC Energy is publicly traded in Canad[+128 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SHRC.CN",
"name": "Sharc International Systems Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 61.437584,
"sentiment_score": 0.568567,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia, May 30, 202[+365 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "About SHARC Energy\n\n<em>SHARC</em> <em>I[+139 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "SHARC Energy is publicly traded in Canad[+137 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "5521bb21-bdcc-42e0-a495-2792d1e26e66",
"title": "Eos Energy Enterprises Inc (EOSE) Announces Pricing of $225 Million Convertible Senior Notes Offering | EOSE stock news",
"description": "Summary Eos Energy Enterprises Inc (EOSE), a leader in innovative energy storage solutions, announced on May 30, 2025, the pricing of its $225 million aggregate",
"keywords": "GuruFocus, Article, News, GuruFocus News, EOSE",
"snippet": "Summary\n\nEos Energy Enterprises Inc (EOSE, Financial), a leader in innovative energy storage solutions, announced on May 30, 2025, the pricing of its $225 milli...",
"url": "https://www.gurufocus.com/news/2898051/eos-energy-enterprises-inc-eose-announces-pricing-of-225-million-convertible-senior-notes-offering-eose-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:04:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EOSE",
"name": "Eos Energy Enterprises, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 142.11859,
"sentiment_score": 0.578575,
"highlights": [
{
"highlight": "Summary\n\n<em>Eos</em> <em>Energy</em> <e[+229 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+320 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+341 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Eos</em> <em>Energy</em> <em>Enterprises</em> <em>Inc</em> (EOSE) Announces Pricing of $225 Million Convertible Senior Notes Offering | EOSE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "EOSEW",
"name": "Eos Energy Enterprises, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 142.11859,
"sentiment_score": 0.578575,
"highlights": [
{
"highlight": "Summary\n\n<em>Eos</em> <em>Energy</em> <e[+229 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+320 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+341 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Eos</em> <em>Energy</em> <em>Enterprises</em> <em>Inc</em> (EOSE) Announces Pricing of $225 Million Convertible Senior Notes Offering | EOSE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "a42f6199-6dbe-44e7-ad47-10ae9bc8c56e",
"title": "Eos Energy Enterprises Inc (EOSE) Announces Pricing of Common Stock Offering | EOSE stock news",
"description": "Summary Eos Energy Enterprises Inc (EOSE), a leader in innovative energy storage solutions, announced on May 30, 2025, the pricing of its public offering of 18,",
"keywords": "GuruFocus, Article, News, GuruFocus News, EOSE",
"snippet": "Summary\n\nEos Energy Enterprises Inc (EOSE, Financial), a leader in innovative energy storage solutions, announced on May 30, 2025, the pricing of its public off...",
"url": "https://www.gurufocus.com/news/2898050/eos-energy-enterprises-inc-eose-announces-pricing-of-common-stock-offering-eose-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:04:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EOSE",
"name": "Eos Energy Enterprises, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 155.32678,
"sentiment_score": 0.4325,
"highlights": [
{
"highlight": "Summary\n\n<em>Eos</em> <em>Energy</em> <e[+302 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+228 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+213 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: What is the purpose of the commo[+336 characters]",
"sentiment": 0.7941,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Eos</em> <em>Energy</em> <em>Enterprises</em> <em>Inc</em> (EOSE) Announces Pricing of Common Stock Offering | EOSE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "EOSEW",
"name": "Eos Energy Enterprises, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 155.32678,
"sentiment_score": 0.4325,
"highlights": [
{
"highlight": "Summary\n\n<em>Eos</em> <em>Energy</em> <e[+302 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+228 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+213 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: What is the purpose of the commo[+336 characters]",
"sentiment": 0.7941,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Eos</em> <em>Energy</em> <em>Enterprises</em> <em>Inc</em> (EOSE) Announces Pricing of Common Stock Offering | EOSE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8ba8f72d-9c15-40a7-a3a4-c0b1d9fd0404",
"title": "DKL Stock: A Lower-Risk 10.93%-Yielding Energy Sector Play?",
"description": "DKL stock, which offers a high dividend yield, could come with less risk than an upstream energy company. Full story here.",
"keywords": "",
"snippet": "DKL Stock: A Less Risky, 10.93%-Yielding Play on Energy Sector?\n\nAdvertisement\n\nDKL Stock Remains Under the Radar for Now…\n\nIn the income investing spotlight ...",
"url": "https://www.incomeinvestors.com/dkl-stock-less-risky-10-93-percent-yielding-play-energy-sector/76637/",
"image_url": "https://www.incomeinvestors.com/wp-content/uploads/2025/05/oil-pipeline-2025-03-13-05-04-21-utc.jpg",
"language": "en",
"published_at": "2025-05-30T11:06:00.000000Z",
"source": "incomeinvestors.com",
"relevance_score": null,
"entities": [
{
"symbol": "DKL",
"name": "Delek Logistics Partners, LP",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 68.80665,
"sentiment_score": 0.6212,
"highlights": [
{
"highlight": "With this in mind, take a look at <em>De[+253 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "(Source: “Overview,” <em>Delek</em> [+287 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b2efc126-8cb7-4de3-95db-8254a7af9c1b",
"title": "Ally Financial (ALLY) Anticipates Stable Q2 Net Interest Margin | ALLY Stock News",
"description": "Ally Financial (ALLY) projects its net interest margin (NIM) for the second quarter to remain largely unchanged compared to the previous quarter. This outlook s",
"keywords": "GuruFocus, Article, News, GuruFocus News, ALLY",
"snippet": "Ally Financial (ALLY, Financial) projects its net interest margin (NIM) for the second quarter to remain largely unchanged compared to the previous quarter. Thi...",
"url": "https://www.gurufocus.com/news/2898782/ally-financial-ally-anticipates-stable-q2-net-interest-margin-ally-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00002YU9.png?20",
"language": "en",
"published_at": "2025-05-30T15:46:56.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALLY",
"name": "Ally Financial Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 75.67615,
"sentiment_score": 0.42885,
"highlights": [
{
"highlight": "<em>Ally</em> <em>Financial</em> (<em>AL[+278 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+272 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+65 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ally</em> <em>Finan[+234 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ally</em> <em>Financial</em> <em>Inc[+313 characters]",
"sentiment": 0.9217,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ally</em> <em>Financial</em> (ALLY) Anticipates Stable Q2 Net Interest Margin | ALLY Stock News",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "c6b6eace-06be-482f-84ca-9c8df4908322",
"title": "Ally Financial (ALLY) Expects Growth in Net Interest Margin This Year | ALLY Stock News",
"description": "Ally Financial (ALLY) anticipates an increase in its net interest margin (NIM) throughout the calendar year. This outlook reflects the company's strategic effor",
"keywords": "GuruFocus, Article, News, GuruFocus News, ALLY",
"snippet": "Ally Financial (ALLY, Financial) anticipates an increase in its net interest margin (NIM) throughout the calendar year. This outlook reflects the company's stra...",
"url": "https://www.gurufocus.com/news/2898781/ally-financial-ally-expects-growth-in-net-interest-margin-this-year-ally-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00002YU9.png?20",
"language": "en",
"published_at": "2025-05-30T15:46:49.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALLY",
"name": "Ally Financial Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 72.828125,
"sentiment_score": 0.457538,
"highlights": [
{
"highlight": "<em>Ally</em> <em>Financial</em> (<em>AL[+239 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+272 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+65 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ally</em> <em>Finan[+234 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ally</em> <em>Financial</em> <em>Inc[+313 characters]",
"sentiment": 0.9217,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ally</em> <em>Financial</em> (ALLY) Expects Growth in Net Interest Margin This Year | ALLY Stock News",
"sentiment": 0.6808,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "760b9877-116c-4fad-8480-557b65b9e35b",
"title": "Tariffs Anticipated to Elevate Used Car Prices, Says ALLY | ALLY Stock News",
"description": "During a presentation at the Bernstein 41st Annual Strategic Decisions Conference in 2025, insights were shared regarding the anticipated impact of tariffs on t",
"keywords": "GuruFocus, Article, News, GuruFocus News, ALLY",
"snippet": "During a presentation at the Bernstein 41st Annual Strategic Decisions Conference in 2025, insights were shared regarding the anticipated impact of tariffs on t...",
"url": "https://www.gurufocus.com/news/2898770/tariffs-anticipated-to-elevate-used-car-prices-says-ally-ally-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00002YU9.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALLY",
"name": "Ally Financial Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 41.107193,
"sentiment_score": 0.3595,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+272 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+65 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ally</em> <em>Finan[+234 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ally</em> <em>Financial</em> <em>Inc[+313 characters]",
"sentiment": 0.9217,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "dcc2594f-c67a-4ef7-b590-866b3e259f7d",
"title": "FingerMotion, Inc. Reports FY 2025 Financial Results | FNGR Stock News",
"description": "FingerMotion (FNGR) reported FY 2025 revenue of $35.61M, a slight 0.5% decline YoY. Net loss increased by 34% to $5.11M, with a per-share loss of $0.09. SM",
"keywords": "GuruFocus, Article, News, GuruFocus News, FNGR",
"snippet": "FingerMotion (FNGR, Financial) reported FY 2025 revenue of $35.61M, a slight 0.5% decline YoY.\n\nNet loss increased by 34% to $5.11M, with a per-share loss of $0...",
"url": "https://www.gurufocus.com/news/2898302/fingermotion-inc-reports-fy-2025-financial-results-fngr-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AQKX.png?20",
"language": "en",
"published_at": "2025-05-30T13:15:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FNGR",
"name": "FingerMotion, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 108.39076,
"sentiment_score": 0.275475,
"highlights": [
{
"highlight": "<em>FingerMotion</em> (FNGR, Financial) [+248 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>FingerMotion</em> repo[+293 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>FingerMotion</em> maintains a positi[+173 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>FingerMotion</em>, <em>Inc</em>. Reports FY 2025 Financial Results | FNGR Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "84cd7f5b-069d-43a0-8bf6-e3818aa065a8",
"title": "Rocket Pharmaceuticals (RCKT) Faces Downgrade Due to Trial Setback | RCKT Stock News",
"description": "Rocket Pharmaceuticals (RCKT) was downgraded by Evercore ISI from \"Outperform\" to \"In Line,\" with its price target significantly reduced from $18 to $5. This do",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCKT",
"snippet": "Rocket Pharmaceuticals (RCKT, Financial) was downgraded by Evercore ISI from \"Outperform\" to \"In Line,\" with its price target significantly reduced from $18 to ...",
"url": "https://www.gurufocus.com/news/2898778/rocket-pharmaceuticals-rckt-faces-downgrade-due-to-trial-setback-rckt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000ARJR.png?20",
"language": "en",
"published_at": "2025-05-30T15:46:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCKT",
"name": "Rocket Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 75.50636,
"sentiment_score": -0.264425,
"highlights": [
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em>[+245 characters]",
"sentiment": -0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em> (RCKT) Faces Downgrade Due to Trial Setback | RCKT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "57286a5f-18e8-419b-a5ed-058403a045c8",
"title": "Rocket Pharmaceuticals (RCKT) Faces Downgrade with New Price Target | RCKT Stock News",
"description": "Evercore ISI analyst Gavin Clark-Gartner has revised his recommendation for Rocket Pharmaceuticals (RCKT), moving it from an Outperform rating to In Line. The u",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCKT",
"snippet": "Evercore ISI analyst Gavin Clark-Gartner has revised his recommendation for Rocket Pharmaceuticals (RCKT, Financial), moving it from an Outperform rating to In ...",
"url": "https://www.gurufocus.com/news/2898720/rocket-pharmaceuticals-rckt-faces-downgrade-with-new-price-target-rckt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000ARJR.png?20",
"language": "en",
"published_at": "2025-05-30T15:15:30.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCKT",
"name": "Rocket Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 76.127045,
"sentiment_score": -0.0683,
"highlights": [
{
"highlight": "Evercore ISI analyst Gavin Clark-Gartner[+314 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em> (RCKT) Faces Downgrade with New Price Target | RCKT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "5a040420-3723-472c-a837-6d98dd7e0280",
"title": "Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News",
"description": "Processa Pharmaceuticals (PCSA) will present three abstracts at the 2025 ASCO Annual Meeting, showcasing advancements in their oncology pipeline. Key pr",
"keywords": "GuruFocus, Article, News, GuruFocus News, PCSA",
"snippet": "Processa Pharmaceuticals (PCSA, Financial) will present three abstracts at the 2025 ASCO Annual Meeting, showcasing advancements in their oncology pipeline.\n\nKe...",
"url": "https://www.gurufocus.com/news/2898591/processa-pharmaceuticals-announces-presentation-and-publication-of-three-abstracts-at-2025-asco-annual-meeting-pcsa-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00009FS4.png?20",
"language": "en",
"published_at": "2025-05-30T14:17:49.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PCSA",
"name": "Processa Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 72.11403,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "<em>Processa</em> <em>Pharmaceuticals</e[+255 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Processa</em> <em>Pharmaceuticals</e[+281 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Processa</em> <em>Pharmaceuticals</em> Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "dbfc4b25-cca3-4439-b9e0-c8010f4584bd",
"title": "Processa Pharmaceuticals (PCSA) Highlights Cancer Drug Advances at ASCO 2025 | PCSA Stock News",
"description": "Processa Pharmaceuticals (PCSA) has announced that three of its abstracts have been accepted for presentation at the 2025 American Society of Clinical Oncology",
"keywords": "GuruFocus, Article, News, GuruFocus News, PCSA",
"snippet": "Processa Pharmaceuticals (PCSA, Financial) has announced that three of its abstracts have been accepted for presentation at the 2025 American Society of Clinica...",
"url": "https://www.gurufocus.com/news/2898575/processa-pharmaceuticals-pcsa-highlights-cancer-drug-advances-at-asco-2025-pcsa-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00009FS4.png?20",
"language": "en",
"published_at": "2025-05-30T14:16:21.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PCSA",
"name": "Processa Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.68605,
"sentiment_score": -0.164925,
"highlights": [
{
"highlight": "<em>Processa</em> <em>Pharmaceuticals</e[+257 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+303 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+298 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Processa</em> <em>Pharmaceuticals</em> (PCSA) Highlights Cancer Drug Advances at ASCO 2025 | PCSA Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "534bd583-6da2-452d-802e-75f3255a48f6",
"title": "Recursion Pharmaceuticals Inc (RXRX) Announces Participation in Key Investor Conferences | RXRX stock news",
"description": "Summary Recursion Pharmaceuticals Inc (RXRX), a prominent clinical stage TechBio company focused on decoding biology to improve lives, announced on May 30, 2025",
"keywords": "GuruFocus, Article, News, GuruFocus News, RXRX",
"snippet": "Summary\n\nRecursion Pharmaceuticals Inc (RXRX, Financial), a prominent clinical stage TechBio company focused on decoding biology to improve lives, announced on ...",
"url": "https://www.gurufocus.com/news/2898280/recursion-pharmaceuticals-inc-rxrx-announces-participation-in-key-investor-conferences-rxrx-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T13:03:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RXRX",
"name": "Recursion Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 183.00833,
"sentiment_score": 0.45262,
"highlights": [
{
"highlight": "Summary\n\n<em>Recursion</em> <em>Pharmace[+229 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+205 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+206 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: What conferences will <em>Recurs[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Recursion</em> <em>Pharmaceuticals</em> <em>Inc</em> (<em>RXRX</em>) Announces Participation in Key Investor Conferences | <em>RXRX</em> stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "de197e01-edbc-4f40-b6cc-08cebd85659e",
"title": "BioCryst Pharmaceuticals Inc (BCRX) Unveils Promising Data on Berotralstat for Hereditary Angioedema | BCRX stock news",
"description": "Summary BioCryst Pharmaceuticals Inc (BCRX) announced new data on May 30, 2025, showcasing the effectiveness of berotralstat in reducing hereditary angioedema (",
"keywords": "GuruFocus, Article, News, GuruFocus News, BCRX",
"snippet": "Summary\n\nBioCryst Pharmaceuticals Inc (BCRX, Financial) announced new data on May 30, 2025, showcasing the effectiveness of berotralstat in reducing hereditary ...",
"url": "https://www.gurufocus.com/news/2898270/biocryst-pharmaceuticals-inc-bcrx-unveils-promising-data-on-berotralstat-for-hereditary-angioedema-bcrx-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T13:01:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BCRX",
"name": "BioCryst Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.55501,
"sentiment_score": 0.315175,
"highlights": [
{
"highlight": "Summary\n\n<em>BioCryst</em> <em>Pharmaceu[+199 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+296 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nWhat is the main focus of the new d[+250 characters]",
"sentiment": 0.168,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BioCryst</em> <em>Pharmaceuticals</em> <em>Inc</em> (BCRX) Unveils Promising Data on Berotralstat for Hereditary Angioedema | BCRX stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "BCRX.MX",
"name": "BioCryst Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.64308,
"sentiment_score": 0.315175,
"highlights": [
{
"highlight": "Summary\n\n<em>BioCryst</em> <em>Pharmaceu[+199 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+296 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nWhat is the main focus of the new d[+250 characters]",
"sentiment": 0.168,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BioCryst</em> <em>Pharmaceuticals</em> <em>Inc</em> (BCRX) Unveils Promising Data on Berotralstat for Hereditary Angioedema | BCRX stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "6dbf2e1b-87da-47af-958a-5c4fb390bf2c",
"title": "Insights on AAL: Key Takeaways from Analyst Conference Call | AAL Stock News",
"description": "An upcoming conference call scheduled for May 30 at 10 a.m. will feature industry insights from analysts Kahyaoglu and Lemarie, focusing on the aerospace, defen",
"keywords": "GuruFocus, Article, News, GuruFocus News, AAL",
"snippet": "An upcoming conference call scheduled for May 30 at 10 a.m. will feature industry insights from analysts Kahyaoglu and Lemarie, focusing on the aerospace, defen...",
"url": "https://www.gurufocus.com/news/2898776/insights-on-aal-key-takeaways-from-analyst-conference-call-aal-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000ABD.png?20",
"language": "en",
"published_at": "2025-05-30T15:46:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAL",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 47.478626,
"sentiment_score": 0.10888,
"highlights": [
{
"highlight": "Notably, <em>American</em> <em>Airlines<[+89 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+311 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+304 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+271 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+82 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "520cab8f-a711-4658-aa5f-14556668dfab",
"title": "Agilent (A) Stock Update: Post-Earnings Insights and Analyst Perspective | A Stock News",
"description": "Agilent Technologies (A) experienced stock pressure prior to its earnings announcement, influenced primarily by challenges within the life science tools segment",
"keywords": "GuruFocus, Article, News, GuruFocus News, A",
"snippet": "Agilent Technologies (A, Financial) experienced stock pressure prior to its earnings announcement, influenced primarily by challenges within the life science to...",
"url": "https://www.gurufocus.com/news/2898566/agilent-a-stock-update-postearnings-insights-and-analyst-perspective-a-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000009AO.png?20",
"language": "en",
"published_at": "2025-05-30T14:15:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "A.MX",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 53.735176,
"sentiment_score": 0.387533,
"highlights": [
{
"highlight": "<em>Agilent</em> <em>Technologies</em> ([+308 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+304 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Agilent</em> <em>Te[+251 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0HAV.L",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 53.733723,
"sentiment_score": 0.387533,
"highlights": [
{
"highlight": "<em>Agilent</em> <em>Technologies</em> ([+308 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+304 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Agilent</em> <em>Te[+251 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 53.733795,
"sentiment_score": 0.387533,
"highlights": [
{
"highlight": "<em>Agilent</em> <em>Technologies</em> ([+308 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+304 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Agilent</em> <em>Te[+251 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A1GI34.SA",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 53.73267,
"sentiment_score": 0.387533,
"highlights": [
{
"highlight": "<em>Agilent</em> <em>Technologies</em> ([+308 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+304 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Agilent</em> <em>Te[+251 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "44a332f0-99bd-43ee-bb87-7404c7803baf",
"title": "Choice Hotels (CHH) Price Target Reduced by Morgan Stanley Analyst | CHH Stock News",
"description": "Morgan Stanley's analyst, Stephen Grambling, has adjusted the price target for Choice Hotels (CHH), lowering it from $115 to $113. Despite this reduction, the a",
"keywords": "GuruFocus, Article, News, GuruFocus News, CHH",
"snippet": "Morgan Stanley's analyst, Stephen Grambling, has adjusted the price target for Choice Hotels (CHH, Financial), lowering it from $115 to $113. Despite this reduc...",
"url": "https://www.gurufocus.com/news/2898173/choice-hotels-chh-price-target-reduced-by-morgan-stanley-analyst-chh-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007CI.png?20",
"language": "en",
"published_at": "2025-05-30T12:49:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CHH",
"name": "Choice Hotels International, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 55.407745,
"sentiment_score": 0.4763,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+319 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+315 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+276 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+325 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Choice</em> <em>Hot[+324 characters]",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Choice</em> <em>Hotels</em> <em>Inte[+186 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 88.8881,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Choice Hotels (CHH) Price Target Reduced by <em>Morgan</em> <em>Stanley</em> Analyst | CHH Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "27b4359b-4974-4871-aaef-3444116e4f9d",
"title": "G-III Apparel Group Ltd (GIII) Announces Upcoming Earnings Release and Conference Call | GIII stock news",
"description": "Summary G-III Apparel Group Ltd (GIII), a prominent global fashion company known for its expertise in design, sourcing, and marketing, has announced that it wil",
"keywords": "GuruFocus, Article, News, GuruFocus News, GIII",
"snippet": "Summary\n\nG-III Apparel Group Ltd (GIII, Financial), a prominent global fashion company known for its expertise in design, sourcing, and marketing, has announced...",
"url": "https://www.gurufocus.com/news/2898049/giii-apparel-group-ltd-giii-announces-upcoming-earnings-release-and-conference-call-giii-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:03:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIII",
"name": "G-III Apparel Group, Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 200.25479,
"sentiment_score": 0.1591,
"highlights": [
{
"highlight": "Summary\n\n<em>G</em>-<em>III</em> <em>App[+328 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>G</em>-<em>III</em> <em>Apparel</em> <em>Group</em> <em>Ltd</em> (GIII) Announces Upcoming Earnings Release and Conference Call | GIII stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "295d21e1-e889-4fca-8717-eef322457e01",
"title": "ServiceNow (NOW) Inspires Zscaler's Strategic Market Approach | NOW Stock News",
"description": "Zscaler has received an increased price target from Needham, moving up from $240 to $310, with the firm maintaining a Buy rating. The company's recent performan",
"keywords": "GuruFocus, Article, News, GuruFocus News, NOW",
"snippet": "Zscaler has received an increased price target from Needham, moving up from $240 to $310, with the firm maintaining a Buy rating. The company's recent performan...",
"url": "https://www.gurufocus.com/news/2898775/servicenow-now-inspires-zscalers-strategic-market-approach-now-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00009AMS.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NOW",
"name": "ServiceNow, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 55.55902,
"sentiment_score": 0.439122,
"highlights": [
{
"highlight": "They aim to replicate the successful mod[+269 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+251 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+243 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+266 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>ServiceNow</em> <em[+260 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ServiceNow</em> <em>Inc</em> (NOW) s[+248 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ServiceNow</em> <em>Inc</em> (NOW) r[+108 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ServiceNow</em> (NOW) Inspires Zscaler's Strategic Market Approach | NOW Stock News",
"sentiment": 0.4404,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "1c984628-4c56-48b0-8447-d8343f8be1e4",
"title": "Ambarella (AMBA) Price Target Reduced by Needham | AMBA Stock News",
"description": "Needham has adjusted its price target for Ambarella (AMBA), lowering it from $110 to $90 while maintaining a Buy rating. Despite the company's first-quarter res",
"keywords": "GuruFocus, Article, News, GuruFocus News, AMBA",
"snippet": "Needham has adjusted its price target for Ambarella (AMBA, Financial), lowering it from $110 to $90 while maintaining a Buy rating. Despite the company's first-...",
"url": "https://www.gurufocus.com/news/2898774/ambarella-amba-price-target-reduced-by-needham-amba-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00008TNB.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:47.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMBA",
"name": "Ambarella, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 64.371056,
"sentiment_score": 0.1805,
"highlights": [
{
"highlight": "Needham has adjusted its price target fo[+317 characters]",
"sentiment": -0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+251 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ambarella</em> <em>[+239 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ambarella</em> <em>Inc</em> (AMBA) i[+268 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ambarella</em> (AMBA) Price Target Reduced by Needham | AMBA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "7f146550-887f-41e0-9b31-6c39599de4d8",
"title": "Roth Capital Adjusts Ambarella (AMBA) Price Target Amid Market Conditions | AMBA Stock News",
"description": "Roth Capital has revised its price target for Ambarella (AMBA), lowering it from $85 to $65 while maintaining a Neutral rating on the stock. The adjustment foll",
"keywords": "GuruFocus, Article, News, GuruFocus News, AMBA",
"snippet": "Roth Capital has revised its price target for Ambarella (AMBA, Financial), lowering it from $85 to $65 while maintaining a Neutral rating on the stock. The adju...",
"url": "https://www.gurufocus.com/news/2898359/roth-capital-adjusts-ambarella-amba-price-target-amid-market-conditions-amba-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00008TNB.png?20",
"language": "en",
"published_at": "2025-05-30T13:31:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMBA",
"name": "Ambarella, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 60.917248,
"sentiment_score": 0.160638,
"highlights": [
{
"highlight": "Roth Capital has revised its price targe[+246 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+251 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ambarella</em> <em>[+239 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ambarella</em> <em>Inc</em> (AMBA) i[+268 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Roth Capital Adjusts <em>Ambarella</em> (AMBA) Price Target Amid Market Conditions | AMBA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0YU1.L",
"name": "Ambarella, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 60.86692,
"sentiment_score": 0.160638,
"highlights": [
{
"highlight": "Roth Capital has revised its price targe[+246 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+251 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ambarella</em> <em>[+239 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ambarella</em> <em>Inc</em> (AMBA) i[+268 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Roth Capital Adjusts <em>Ambarella</em> (AMBA) Price Target Amid Market Conditions | AMBA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "9e5772ce-0d93-4365-a9af-87632271b9f0",
"title": "Guess (GES) Stock Rating Reiterated with a Price Target of $23.00 | GES Stock News",
"description": "On May 30, 2025, Small Cap Consumer Research released an analyst rating update for Guess (GES). The analyst, Eric Beder, reiterated a 'Buy' rating for the compa",
"keywords": "GuruFocus, Article, News, GuruFocus News, GES",
"snippet": "On May 30, 2025, Small Cap Consumer Research released an analyst rating update for Guess (GES, Financial). The analyst, Eric Beder, reiterated a 'Buy' rating fo...",
"url": "https://www.gurufocus.com/news/2898350/guess-ges-stock-rating-reiterated-with-a-price-target-of-2300-ges-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000B63.png?20",
"language": "en",
"published_at": "2025-05-30T13:30:40.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GES",
"name": "Guess', Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 44.885372,
"sentiment_score": 0.210071,
"highlights": [
{
"highlight": "On May 30, 2025, Small Cap Consumer Rese[+196 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This report by Eric Beder confirms consi[+212 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and market watchers can consid[+275 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Inc</em> (GES, Financial) is $16.00 [+318 characters]",
"sentiment": -0.3527,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+47 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Guess</em> (GES) Stock Rating Reiterated with a Price Target of $23.00 | GES Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "2ab2d45d-2bd6-4a99-ba90-045a231a49c2",
"title": "Morgan Stanley Adjusts Price Target for MGM to $37, Maintains Equal Weight Rating | MGM Stock News",
"description": "Morgan Stanley has updated its price target for MGM Resorts (MGM), increasing it from $36 to $37 while maintaining an Equal Weight rating on the stock. This dec",
"keywords": "GuruFocus, Article, News, GuruFocus News, MGM",
"snippet": "Morgan Stanley has updated its price target for MGM Resorts (MGM, Financial), increasing it from $36 to $37 while maintaining an Equal Weight rating on the stoc...",
"url": "https://www.gurufocus.com/news/2898163/morgan-stanley-adjusts-price-target-for-mgm-to-37-maintains-equal-weight-rating-mgm-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008DQ.png?20",
"language": "en",
"published_at": "2025-05-30T12:48:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MGM",
"name": "MGM Resorts International",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 59.25985,
"sentiment_score": 0.43714,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+301 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+273 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+310 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>MGM</em> <em>Resort[+233 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 81.14527,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> has upd[+140 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Morgan</em> <em>Stanley</em> Adjusts Price Target for MGM to $37, Maintains Equal Weight Rating | MGM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "a3ee3c4b-9dee-43e4-ba88-189d60eaac5c",
"title": "Unity (U) Sees Sharp Increase in Call Option Activity | U Stock News",
"description": "Unity (U) Software has experienced a significant surge in call option activity, with 52,236 calls traded, which is four times the typical volume. The implied vo",
"keywords": "GuruFocus, Article, News, GuruFocus News, U",
"snippet": "Unity (U, Financial) Software has experienced a significant surge in call option activity, with 52,236 calls traded, which is four times the typical volume. The...",
"url": "https://www.gurufocus.com/news/2898772/unity-u-sees-sharp-increase-in-call-option-activity-u-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BY8L.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "U",
"name": "Unity Software Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 43.132698,
"sentiment_score": 0.253867,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+273 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+249 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+332 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Unity</em> <em>Soft[+314 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Unity</em> <em>Software</em> <em>Inc[+232 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "cc026f19-08ef-46f5-962d-39a7f2ec9b9b",
"title": "Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow | CRLBF Stock News",
"description": "Cresco Labs (CRLBF) reported first quarter revenue of $166 million in 2025. The company achieved an operating cash flow of $30 million. Despite a net",
"keywords": "GuruFocus, Article, News, GuruFocus News, CRLBF",
"snippet": "Cresco Labs (CRLBF, Financial) reported first quarter revenue of $166 million in 2025.\n\nThe company achieved an operating cash flow of $30 million.\n\nDespite a n...",
"url": "https://www.gurufocus.com/news/2897932/cresco-labs-continues-track-record-of-delivering-strong-operating-cash-flow-crlbf-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000KO9.png?20",
"language": "en",
"published_at": "2025-05-30T11:45:22.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CRLBF",
"name": "Cresco Labs Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 118.33966,
"sentiment_score": 0.606017,
"highlights": [
{
"highlight": "<em>Cresco</em> <em>Labs</em> (<em>CRLBF[+283 characters]",
"sentiment": 0.7833,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>CRLBF</em>), a leading cannabis com[+262 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This performance underscores <em>Cresco<[+289 characters]",
"sentiment": 0.8618,
"highlighted_in": "main_text"
},
{
"highlight": "This marks <em>Cresco</em> <em>Labs</em>[+290 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "This financial performance reinforces <e[+140 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cresco</em> <em>Labs</em> Continues Track Record of Delivering Strong Operating Cash Flow | <em>CRLBF</em> Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
},
{
"symbol": "CRLWF",
"name": "Cresco Labs Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 81.802505,
"sentiment_score": 0.72722,
"highlights": [
{
"highlight": "<em>Cresco</em> <em>Labs</em> (CRLBF, Fi[+274 characters]",
"sentiment": 0.7833,
"highlighted_in": "main_text"
},
{
"highlight": "This performance underscores <em>Cresco<[+289 characters]",
"sentiment": 0.8618,
"highlighted_in": "main_text"
},
{
"highlight": "This marks <em>Cresco</em> <em>Labs</em>[+290 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "This financial performance reinforces <e[+140 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cresco</em> <em>Labs</em> Continues Track Record of Delivering Strong Operating Cash Flow | CRLBF Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
},
{
"symbol": "CL.CN",
"name": "Cresco Labs Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 81.78956,
"sentiment_score": 0.72722,
"highlights": [
{
"highlight": "<em>Cresco</em> <em>Labs</em> (CRLBF, Fi[+274 characters]",
"sentiment": 0.7833,
"highlighted_in": "main_text"
},
{
"highlight": "This performance underscores <em>Cresco<[+289 characters]",
"sentiment": 0.8618,
"highlighted_in": "main_text"
},
{
"highlight": "This marks <em>Cresco</em> <em>Labs</em>[+290 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "This financial performance reinforces <e[+140 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cresco</em> <em>Labs</em> Continues Track Record of Delivering Strong Operating Cash Flow | CRLBF Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "a711edcd-9e55-4761-92ae-84f6fbafc6dd",
"title": "Palantir (PLTR) Expands Federal Contracts and Opportunities | PLTR Stock News",
"description": "In March, a new directive was introduced by the administration to enhance the exchange of data among federal bodies. Following this, Palantir Technologies (PLTR",
"keywords": "GuruFocus, Article, News, GuruFocus News, PLTR",
"snippet": "In March, a new directive was introduced by the administration to enhance the exchange of data among federal bodies. Following this, Palantir Technologies (PLTR...",
"url": "https://www.gurufocus.com/news/2898771/palantir-pltr-expands-federal-contracts-and-opportunities-pltr-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AA2O.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PLTR",
"name": "Palantir Technologies Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 50.705162,
"sentiment_score": 0.480386,
"highlights": [
{
"highlight": "Following this, <em>Palantir</em> <em>Te[+284 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+307 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+331 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Palantir</em> <em>T[+262 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Palantir</em> <em>Technologies</em> [+279 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "2a3b4a0b-5dbe-49f3-b336-8341f70b2baa",
"title": "Citizens Financial Group Announces Redemption of Subordinated Notes | CFG Stock News",
"description": "Citizens Financial Group, Inc. (CFG) announces the redemption of its 4.35% Fixed-Rate Subordinated Notes. The redemption will occur on July 3, 2025, wit",
"keywords": "GuruFocus, Article, News, GuruFocus News, CFG",
"snippet": "Citizens Financial Group, Inc. (CFG, Financial) announces the redemption of its 4.35% Fixed-Rate Subordinated Notes.\n\nThe redemption will occur on July 3, 2025,...",
"url": "https://www.gurufocus.com/news/2898769/citizens-financial-group-announces-redemption-of-subordinated-notes-cfg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00002EQZ.png?20",
"language": "en",
"published_at": "2025-05-30T15:45:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CFG",
"name": "Citizens Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 69.3876,
"sentiment_score": 0.139925,
"highlights": [
{
"highlight": "<em>Citizens</em> <em>Financial</em> <em[+376 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Headquartered in Providence, Rhode Islan[+316 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "For further details, visit <em>Citizens<[+101 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Citizens</em> <em>Financial</em> Group Announces Redemption of Subordinated Notes | CFG Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "bf1d08f6-03b3-4949-9bbd-dc68ee0a8578",
"title": "Citizens Financial Group to Participate at the Morgan Stanley U.S. Financials Conference",
"description": "Citizens Financial Group, Inc. (NYSE: CFG) announced today that Senior Vice Chair and Head of Commercial Banking Don McCree will participate at the Morgan Stan",
"keywords": "GuruFocus, Article, News, Business Wire, NYSE:CFG",
"snippet": "Citizens Financial Group, Inc. (NYSE: CFG) announced today that Senior Vice Chair and Head of Commercial Banking Don McCree will participate at the Morgan Stanl...",
"url": "https://www.gurufocus.com/news/2898664/citizens-financial-group-to-participate-at-the-morgan-stanley-us-financials-conference",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T15:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CFG",
"name": "Citizens Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 91.55878,
"sentiment_score": 0.0593,
"highlights": [
{
"highlight": "<em>Citizens</em> <em>Financial</em> <em[+358 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Citizens</em> <em>Financial</e[+220 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Citizens</em> <em>Financial</em> Group to Participate at the Morgan Stanley U.S. Financials Conference",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 91.8401,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(NYSE: CFG) announced today that Senior [+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Citizens Financial Group to Participate at the <em>Morgan</em> <em>Stanley</em> U.S. Financials Conference",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "87f5bb72-3d9c-4806-bb3e-ddfc233f5d3d",
"title": "Voxtur Announces Financial Results for the Q1 2025 - Ended March 31, 2025",
"description": "**media[641400]**",
"keywords": "Voxtur, Announces, Financial, Results, for, the, Q1, 2025, -, Ended, March, 31, , 2025",
"snippet": "TORONTO and TAMPA, Fla., May 30, 2025 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (\"Voxtur\" or the \"Company\"), a North American techno...",
"url": "https://www.manilatimes.net/2025/05/30/tmt-newswire/globenewswire/voxtur-announces-financial-results-for-the-q1-2025-ended-march-31-2025/2124119",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/30/641400.png",
"language": "en",
"published_at": "2025-05-30T12:44:33.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "ILATF",
"name": "Voxtur Analytics Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 25.565601,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "., May 30, 2025 (GLOBE NEWSWIRE) -- <em>[+292 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VXTRF",
"name": "VOXTUR ANALYTICS CORP",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 37.58925,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "., May 30, 2025 (GLOBE NEWSWIRE) -- <em>[+301 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Voxtur's common shares are traded on the[+203 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "83d4c02c-843f-4f9a-825d-a9242187b2e7",
"title": "UBS Boosts Price Target for Citizens Financial (CFG) After Investor Meetings | CFG Stock News",
"description": "UBS has increased its price target for Citizens Financial (CFG) from $50 to $53, while maintaining a Buy rating on the stock. This decision follows a series of",
"keywords": "GuruFocus, Article, News, GuruFocus News, CFG",
"snippet": "UBS has increased its price target for Citizens Financial (CFG, Financial) from $50 to $53, while maintaining a Buy rating on the stock. This decision follows a...",
"url": "https://www.gurufocus.com/news/2898054/ubs-boosts-price-target-for-citizens-financial-cfg-after-investor-meetings-cfg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00002EQZ.png?20",
"language": "en",
"published_at": "2025-05-30T12:15:15.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CFG",
"name": "Citizens Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 66.10054,
"sentiment_score": 0.453388,
"highlights": [
{
"highlight": "UBS has increased its price target for <[+246 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "The management's tone was described as o[+211 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+306 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+270 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+300 characters]",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Citizens</em> <em>F[+266 characters]",
"sentiment": 0.9246,
"highlighted_in": "main_text"
},
{
"highlight": "UBS Boosts Price Target for <em>Citizens</em> <em>Financial</em> (CFG) After Investor Meetings | CFG Stock News",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HYP.L",
"name": "Citizens Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 66.09641,
"sentiment_score": 0.453388,
"highlights": [
{
"highlight": "UBS has increased its price target for <[+246 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "The management's tone was described as o[+211 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+306 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+270 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+300 characters]",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Citizens</em> <em>F[+266 characters]",
"sentiment": 0.9246,
"highlighted_in": "main_text"
},
{
"highlight": "UBS Boosts Price Target for <em>Citizens</em> <em>Financial</em> (CFG) After Investor Meetings | CFG Stock News",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "9ca9524c-140a-487a-8f50-51d98597fad7",
"title": "G-III Apparel Group Announces Date for First Quarter Fiscal 2026 Results",
"description": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. ( GIII) a global fashion leader with expertise in design, sourcing, and marketing, today",
"keywords": "GuruFocus, Article, News, Marketwired, GIII",
"snippet": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. ( GIII) a global fashion leader with expertise in design, sourcing, and marketing, today an...",
"url": "https://www.gurufocus.com/news/2898005/giii-apparel-group-announces-date-for-first-quarter-fiscal-2026-results",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:00:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIII",
"name": "G-III Apparel Group, Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 72.09911,
"sentiment_score": 0,
"highlights": [
{
"highlight": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) [+352 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>G</em>-<em>III</em> <em>Appare[+356 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3275,
"sentiment_avg": 0.2977914111962464
}
]
}
Other details
Entity count
- 32,649